Taking people in United StatesNo phase
Complex Aneurysm Registry - Real-World Evidence Data Collection for Intracranial Aneurysm Treatment Devices
Key facts
- Who runs it
- Microvention-Terumo, Inc.
- Where
- Albany, Charleston, Cincinnati, Columbus, Englewood, Fort Lauderdale, Great Neck, Greenville, Hartford, Hollywood, Honolulu, Iowa City, Jacksonville, Knoxville, Louisville, Miami Beach, Milwaukee, Minneapolis, Morgantown, New York, Oklahoma City, Orlando, Tampa, The Bronx, Toledo, Traverse City, and Walnut Creek, United StatesSee the 27 sites
- Trial code
- Status
- Recruiting
- People taking part
- 750 people, planned
- Started
- 19 Feb 2024
- Expected to end
- Jan 2029
- Type of study
- Observational
- Treatments tested
- Commercially available MicroVention Intracranial Aneurysm Treatment Devices
- Record updated
- 10 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patient must have a single ruptured or unruptured IA for which endovascular treatment has been determined appropriate
- Patient will be treated using a commercially available MicroVention implant device as the primary treatment device and the decision to use this device has been made by the treating physician outside the context of the CAR study and prior to enrollment. Note: For the purposes of this protocol, ancillary/accessory devices such as balloon catheters and other access devices are not considered primary treatment devices
- Patient or patient 's legally authorized representative (LAR) has provided written informed consent prior to treatment and no later than 48 hours post procedure for emergent treatment of ruptured aneurysms
- Patient must be considered by the treating physician to be available for and able to complete study follow-up visits
Who cannot take part
- Target aneurysm has been previously treated via surgical or endovascular means
- Patient is enrolled in another device or drug study in which participation could confound study results
- Patient has been previously enrolled into this study
- Patient has a life expectancy of less than 1 year due to other illness or condition (in addition to an intracranial aneurysm)
Where in United States
- Albany Medical CenterAlbany, United StatesContact: Wendy StewartTaking people
- Medical University of South CarolinaCharleston, United StatesContact: Meredith RobinsonTaking people
- Mayfield ClinicCincinnati, United StatesContact: Lauren MurphyTaking people
- Ohio State University Wexner Medical CenterColumbus, United StatesContact: Uchechi OkaforTaking people
- Swedish Medical CenterEnglewood, United StatesContact: Ashley ThompsonTaking people
- Broward Health Medical CenterFort Lauderdale, United StatesContact: Laura HudsonTaking people
- North Shore University HospitalGreat Neck, United StatesContact: Betsy MonclairTaking people
- Prisma Health Greenville Memorial HospitalGreenville, United StatesContact: Shawn ManosTaking people
- Hartford HospitalHartford, United StatesContact: Aditya VajjaTaking people
- Memorial Regional HospitalHollywood, United StatesContact: Belkis Wandique, BSN, RNTaking people
- The Queen's Medical Center Neuroscience InstituteHonolulu, United StatesContact: Kelly DiedrichTaking people
- University of Iowa Hospitals & ClinicsIowa City, United StatesContact: Heena OlaldeTaking people
- Baptist Medical Center JacksonvilleJacksonville, United StatesContact: Montserrat Lara PetrickTaking people
- Fort Sanders Regional Medical CenterKnoxville, United StatesContact: Cameron CarterTaking people
- Norton Neuroscience InstituteLouisville, United StatesContact: Trina DeForrestTaking people
- Mount Sinai Medical Center - MiamiMiami Beach, United StatesContact: Juan Vinardell LorenzoTaking people
- Advocate Aurora St. Lukes Medical CenterMilwaukee, United StatesContact: Stacie BishopTaking people
- Abbott-Northwestern HospitalMinneapolis, United StatesContact: Nimco EssaTaking people
- West Virginia University HospitalMorgantown, United StatesContact: Jennifer DomicoTaking people
- The Mount Sinai Hospital - New York CityNew York, United StatesContact: Emily SvednesenTaking people
- University of Oklahoma Health Sciences CenterOklahoma City, United StatesContact: Michael OminiTaking people
- Orlando Regional Medical CenterOrlando, United StatesContact: Diana MondragonTaking people
- Tampa General HospitalTampa, United StatesContact: Shalini NampallyTaking people
- Montefiore Medical CenterThe Bronx, United StatesContact: Genesis LirianoTaking people
- ProMedica Toledo HospitalToledo, United StatesContact: Jennifer DuraTaking people
- Munson Medical CenterTraverse City, United StatesContact: DeAnn MosherTaking people
- Walnut Creek Medical CenterWalnut Creek, United StatesContact: Melenie AaronTaking people
About the trial
What the trial wants to find out
To collect real-world evidence allowing assessment of functional, imaging, and safety outcomes of commercially available MicroVention devices used for the endovascular treatment of intracranial aneurysms (IA) at the direction of the treating physician.
Treatments tested
- Commercially available MicroVention Intracranial Aneurysm Treatment Devices
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 10 November 2026